DEFECT OF CELL-MEDIATED IMMUNE-RESPONSE AGAINST HEPATITIS-B VIRUS - AN INDICATION FOR PATHOGENESIS OF HEPATITIS-B-VIRUS-ASSOCIATED MEMBRANOUS NEPHROPATHY
Cy. Lin et al., DEFECT OF CELL-MEDIATED IMMUNE-RESPONSE AGAINST HEPATITIS-B VIRUS - AN INDICATION FOR PATHOGENESIS OF HEPATITIS-B-VIRUS-ASSOCIATED MEMBRANOUS NEPHROPATHY, Nephron, 76(2), 1997, pp. 176-185
To elucidate the questions of why not all patients with hepatitis B vi
rus (HBV) infection develop HBV membranous nephropathy (HBVMN), we fir
st measured serum HBe circulating immune complex (CIC) during the acut
e nephrotic phase of HBVMN and in HBV carriers, We found that the leve
l of HBe CIC was low in the HBVMN patients and absent either in HBsAg/HBeAg+ patients without HBVMN or HBsAg+/HBeAg- asymptomatic carriers,
Second, we needed to characterize the cellular immune response to HBV
in patients with HBVMN, However, lack of a suitable autologous effect
or/target cell system makes a precise study of HBVMN pathogenesis diff
icult. In the present study, we established a model system by using au
tologous HBcAg-expressing Epstein-Barr-virus-immortalized lymphoblasto
id cell lines (LCL) as stimulator/target cells, Both proliferative res
ponse after stimulation with HBcAg and cytotoxic activity against auto
logous HBcAg-expressing LCL of the peripheral blood T cells obtained f
rom the HBVMN patients and HBsAg carriers could be measured, Using aut
ologous HBcAg-expressing LCL as stimulator/target cells for the study
of HBcAg-specific cytotoxic T lymphocytes. we found that HBVMN patient
s had lower cytotoxic activity than did both HBV carriers and HBsAg-/H
BsAb+, HBeAg-/HBeAb+ children, From the in vitro cytokine production s
tudy of peripheral blood T cells after stimulation with HBcAg, we foun
d that T-helper-cell-1-related IL-2 and IFN-gamma productions were ver
y low in HBVMN patients but T-helper-cell-2-related IL-10 production w
as higher in HBsAg+/HBeAg+ patients with HBVMN than in those without H
BVMN, Based on these findings, we conclude that HBVMN children seem to
have an inadequate cellular immune response to HBcAg.